HOME >> MEDICINE >> NEWS
Statins underprescribed to patients at higher risk of heart disease, Stanford study says

STANFORD, Calif. - The use of cholesterol-lowering drugs known as statins to reduce the risk of heart disease has exploded in recent years, but a new Stanford University School of Medicine study shows that doctors are prescribing them in only half of their visits with patients who would benefit most from them.

Based on the findings, the researchers say physicians should be more aggressive in investigating statin therapy for patients with a high or moderate risk of heart disease, and that patients should ask to have their cholesterol levels checked regularly.

The findings, published in the May 31 issue of the Public Library of Science-Medicine, come at a time when many Americans are still reeling from recent reports that some prescription drugs, including the painkiller Vioxx and postmenopausal hormone therapy, were overprescribed to patients who had little to gain from them.

"You have to look at drug therapy on a case-by-case basis. We have many situations where drugs are misused or overused," said lead author Jun Ma, MD, PhD, research associate at the Stanford Prevention Research Center. "In this particular case, although we did observe some inappropriate use of statins in low-risk patients, the predominant problem appears to be underuse in higher risk patients."

Since their introduction 17 years ago, statins have become the most prescribed class of drugs in the United States, with more than 126 million prescriptions filled in 2004. Statins reduce the level of cholesterol produced by the liver while boosting the liver's ability to remove LDL cholesterol, the so-called "bad" cholesterol, from the blood. High LDL cholesterol levels increase the risk for heart disease. Each year, more than half a million people die from heart disease, making it the No. 1 killer among both men and women.

Randall Stafford, MD, PhD, associate professor of medicine at the Stanford Prevention Research Center and senior author of the st
'"/>

Contact: Susan Ipaktchian
susani@stanford.edu
650-725-5375
Stanford University Medical Center
30-May-2005


Page: 1 2 3

Related medicine news :

1. Statins linked to lower risk of infection
2. Statins protect smokers from lung damage
3. Statins reduce risk of stroke in heart patients
4. Statins prove life-saving in patients with acute coronary syndromes
5. Statins may improve circulation in the retina
6. Statins, beta-blockers lessen heart attack risk, says Stanford-Kaiser study
7. Statins have neutral effect on risk of cancer
8. Statins may simulate stem cells for heart repair
9. Statins reduce the risk of stroke and death after carotid artery surgery
10. Statins use associated with lower risk of fractures
11. Statins protect from death from pneumonia

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/29/2017)... ... March 29, 2017 , ... The assembly ... assembly protocols involve many repetitive steps and often scientists require many different versions ... high-throughput needed, and results in a lower error rate and cost saving for ...
(Date:3/29/2017)... , ... March 29, 2017 ... ... and South Hills of Pittsburgh now have easier access to the robotic-assisted ... by Allegheny Health Network (AHN). Orthopaedic surgeons at Forbes Hospital and Jefferson ...
(Date:3/29/2017)... ... ... AvePoint , the Microsoft Cloud expert, is pleased to announce the ... the Riverfront Plaza, 901 East Byrd Street. AvePoint is celebrating with a ribbon-cutting ceremony ... Mayor of Richmond Levar M. Stoney. , Founded in 2001, AvePoint employs more than ...
(Date:3/28/2017)... ... March 28, 2017 , ... Tuesday, March 28, 2017, is the annual ... the Diabetes Risk Test to find out if they are at risk for developing ... light up the evening sky by programming the LAX pylons the color red. Downtown’s ...
(Date:3/28/2017)... CARTERSVILLE, Georgia (PRWEB) , ... March 28, 2017 ... ... analyst to its award-winning team. Ruel Williamson brings his extensive knowledge of appraisals, ... been a leader in the real estate valuation industry for more than 40 ...
Breaking Medicine News(10 mins):
(Date:3/29/2017)... March 29, 2017  Spiral Therapeutics, Inc. today ... Bionure Farma, S.L. for the worldwide exclusive rights ... in the field of otolaryngology for aggregate payments ... The agreement provides Spiral with the option ... differentiated product profile. Under the terms of the ...
(Date:3/29/2017)... 2017   Dynatronics Corporation (NASDAQ: ... Cynthia L. McHenry (Cyndi) as Vice ... leading Dynatronics manufacturing, distribution, and purchasing operations across ... CEO Kelvyn H. Cullimore, Jr. ... process conducted by the company as it continues ...
(Date:3/29/2017)... SILVER SPRING, Md. , March 29, 2017 On ... Ocrevus (ocrelizumab) to treat adult patients with relapsing forms ... (PPMS). This is the first drug approved by the ... by a health care professional.  "Multiple ... life," said Billy Dunn , M.D., director of ...
Breaking Medicine Technology:
Cached News: